Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

multiple myeloma/albumină

Linkul este salvat în clipboard
Pagină 1 din 507 rezultate

Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Serum albumin level, in association with serum interleukin-6 level, is a significant prognostic factor in multiple myeloma patients. The aim of this study was to determine any clinical factors associated with decreased serum albumin level. We retrospectively reviewed the records of 373 patients

Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Renal failure is a common morbidity in multiple myeloma (MM). Although proteinuria has been increasingly reported in malignancies, it is not routinely used to refine risk estimates of survival outcomes in patients with MM. Here we aimed to investigate initial serum albumin and 24-hour daily protein

The albumin and monoclonal protein ratio as prognostic marker for multiple myeloma in the era of novel agents.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Multiple myeloma (MM) is a heterogeneous disease group regarding prognosis, clinical course, and response to therapeutic interventions. Numerous prognostic factors have been identified however there was no consensus about the best prognostic indicators or the proper staging systems. In a previous

Comparison of bromcresol green and agarose protein electrophoresis for quantitation of serum albumin in multiple myeloma.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND The International Staging System for multiple myeloma has increased the importance of accurate measurement of serum albumin. Two common albumin assays, bromcresol green (BCG) and agarose gel protein electrophoresis (PEL), frequently yield discordant results, creating confusion regarding

Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE Since the prognostic significance of the combination of beta-2-microglobulin (beta(2)m) and albumin in multiple myeloma (MM) has been recognized, these two easily obtainable parameters were subsequently employed in the staging systems of Bataille et al. (BSS), the South West Oncology Group

Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
In 71 patients with multiple myeloma the authors evaluated the clinical significance and the prognostic relevance of Bataille's stratification system based on serum beta 2-microglobulin and serum albumin levels. This staging system, which classified the patients to low, intermediate and poor risk

Globulin fraction and albumin: globulin ratio as a predictor of mortality in a South African multiple myeloma cohort

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Multiple myeloma, a hematological malignancy typified by the clonal expansion of bone marrow plasma cells, contributes to one percent of all malignancies worldwide. Despite myeloma only contributing to 10% of all hematological malignancies, it carries significant morbidity owing to its heterogenous

Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Background: Acute kidney injury (AKI) occurs in 12-20% of multiple myeloma (MM) patients. Several studies have shown a reduction of free light chains (FLC) using hemodialysis with High-Cut-Off membranes. However, this technique entails
The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway mediates multiple myeloma (MM) cell proliferation, survival, and development of drug resistance, underscoring the role of mTOR inhibitors, such as rapamycin, with potential anti-MM activity. However, recent data
Sera from a pool of 800 healthy donors and from 3 individual healthy donors were passed through tubulin, actin, thyroglobulin, myoglobin, fetuin, transferrin and albumin immunoadsorbents. Proteins were eluted in all the immunosorbents and were found to be essentially composed of the three major Ig

Comparison of bromcresol purple and capillary protein electrophoresis for quantification of serum albumin in multiple myeloma.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare

Treatment of multiple myeloma with radioactive iodine and radioactive iodinated serum albumin.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare

Influence of protein and albumin levels on serum fructosamine concentration in a diabetic patient with multiple myeloma.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare

[Properties and composition of serum albumin in multiple myeloma].

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Alăturați-vă paginii
noastre de facebook

Cea mai completă bază de date cu plante medicinale susținută de știință

  • Funcționează în 55 de limbi
  • Cure pe bază de plante susținute de știință
  • Recunoașterea ierburilor după imagine
  • Harta GPS interactivă - etichetați ierburile în locație (în curând)
  • Citiți publicațiile științifice legate de căutarea dvs.
  • Căutați plante medicinale după efectele lor
  • Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate

Google Play badgeApp Store badge